Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Upadacitinib improved multiple immune-related conditions in one patient.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Bioregulatory medicine improved the dog's health and recovery from chemotherapy side effects.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

New treatments for alopecia areata show promise in improving hair loss outcomes.

New therapies are being developed that target integrin pathways to treat various diseases.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.